Pfizer Aktie
Kursziele der Pfizer-Aktie in USD
Diese Analysten bewerten die Pfizer-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| DZ BANK | - | - | 06.08.2026 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 25,00 USD | -6,09% | 05.08.2026 | |
| Jefferies & Company Inc. | 34,00 USD | +27,72% | 05.08.2026 | |
| JP Morgan Chase & Co. | 28,00 USD | +5,18% | 04.08.2026 | |
| RBC Capital Markets | 25,00 USD | -6,09% | 30.07.2026 | |
| UBS AG | 27,00 USD | +1,43% | 23.06.2026 | |
| Barclays Capital | 25,00 USD | -6,09% | 28.05.2026 | |
| Goldman Sachs Group Inc. | 26,00 USD | -2,33% | 04.02.2026 |
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| APONTIS PHARMA | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 8 | 0 | 1 | 164,21 GBP | - |
| Bayer | 7 | 2 | 0 | 55,31 EUR | +12,60% |
| Celgene Corp. | 0 | 0 | 0 | - | - |
| EVOTEC SE | 1 | 2 | 0 | 5,70 EUR | +53,39% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| GSK PLC Registered Shs | 2 | 5 | 2 | 21,17 GBP | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 4 | 4 | 0 | 141,00 EUR | 0,00% |
| MorphoSys | 0 | 0 | 0 | - | - |
| Mylan N.V. | 0 | 0 | 0 | - | - |
| Novartis AG | 2 | 6 | 1 | 123,10 CHF | -2,19% |
| Perrigo Company | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 2 | 5 | 1 | 27,14 USD | +1,95% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 5 | 4 | 0 | 93,53 EUR | +23,73% |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Vertex Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |




